Haemonetics Corporation
$5.68B- Market cap
- $4.68B
- Debt
- +$1.24B
- Cash
- −$245.44M
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.58x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
HAE · current priceP/E 50.20x
$102.92Latest market snapshot
Implied fair value · at RELX's multiple
$47.4953.9% below market
2.05 HAE EPS (TTM)×23.17x RELX P/E=$47.49
Market $102.92Implied $47.49
RELX · current priceP/E 23.17x
$35.51Latest market snapshot
Implied fair value · at HAE's multiple
$76.95116.7% above market
1.53 RELX EPS (TTM)×50.20x HAE P/E=$76.95
Market $35.51Implied $76.95